HeyJaredPrecision Pathology Podcast (P³)
Precision Pathology Podcast (P³) features monthly interviews hosted by George J. Netto, MD, Chair of Pathology and Laboratory Medicine at the University of Pennsylvania's Perelman School of Medicine.
- Indexed episodes, last 90 days
- 2
- Latest publication
- Aug 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 17, 2026
Latest episodes
Can Spatial Immune Profiling Improve Oncotype Dx Guidance of Chemotherapy in Breast Cancer? (opens the original)
Read excerpt
Predictions of late recurrence risk in ER+HER2- breast cancer patients remain suboptimal, particularly for patients with intermediate risk determined by the Oncotype Dx Recurrence Score (RS, 16-25). Using spatial proteomics (multiplex immunofluorescence) and spatial transcriptomics, our guest, Zak Kinsella PhD, from the Royal College of Surgeons in Ireland, with his team of co-authors, observed an association between higher stromal tumor-infiltrating CD8+ lymphocyte (sTIL CD8+) density and poor
How CAR T-Cell Therapy Enabled Kidney Transplants for Highly Sensitized Patients (opens the original)
Read excerpt
This episode explains how a novel CAR T-cell approach made kidney transplantation possible for patients previously considered unmatched, and why that could change outcomes for people waiting on dialysis. Dr. Vijay Bhoj, MD, PhD, assistant professor of pathology and cellular immunotherapy at the University of Pennsylvania, walks through the phase 1, multi-institutional trial that combined CD19 and BCMA CAR T-cells to achieve durable antibody reduction and successful transplants. Listen to the Pod
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.